✦ LIBER ✦
Novel therapeutic agents: Lumiracoxib, a novel COX-2 selective inhibitor, is effective in the treatment of episodic tension-type headache
✍ Scribed by E. Packman; B. Packman; H. Thurston; L. Tseng; D. Kellstein
- Book ID
- 119305919
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 43 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1528-8447
No coin nor oath required. For personal study only.